Here, we aimed to examine the role of CK2B in T‐cell exhaustion during resistance to anti‐PD‐1 therapy in NSCLC using scRNA‐seq and in vitro and in vivo experiments. This evidence concerns the gene CSNK2B and non-small cell lung carcinoma.